Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities      
Net income (loss) $ 563,000,000 $ (665,000,000) $ (1,097,000,000)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Non-cash LNG inventory write-downs 0 0 18,000,000
Depreciation and amortization expense 356,000,000 174,000,000 83,000,000
Share-based compensation expense 91,000,000 101,000,000 172,000,000
Non-cash interest expense 75,000,000 77,000,000 59,000,000
Amortization of debt issuance costs, deferred commitment fees, premium and discount 69,000,000 62,000,000 48,000,000
Loss on early extinguishment of debt 100,000,000 135,000,000 124,000,000
Total losses (gains) on derivatives, net 62,000,000 (28,000,000) 168,000,000
Net cash used for settlement of derivative instruments (106,000,000) (45,000,000) (100,000,000)
Impairment expense and loss on disposal of assets 19,000,000 13,000,000 91,000,000
Other (4,000,000) 4,000,000 1,000,000
Changes in operating assets and liabilities:      
Accounts and other receivables (139,000,000) (207,000,000) (1,000,000)
Accounts receivable—related party (2,000,000) 0 0
Inventory (73,000,000) (119,000,000) (28,000,000)
Accounts payable and accrued liabilities 225,000,000 64,000,000 2,000,000
Deferred revenue 34,000,000 42,000,000 (4,000,000)
Other, net (39,000,000) (12,000,000) (19,000,000)
Net cash provided by (used in) operating activities 1,231,000,000 (404,000,000) (483,000,000)
Cash flows from investing activities      
Property, plant and equipment, net (3,357,000,000) (4,356,000,000) (6,853,000,000)
Investment in equity method investment (41,000,000) 0 0
Other 17,000,000 (57,000,000) (131,000,000)
Net cash provided by (used in) investing activities (3,381,000,000) (4,413,000,000) (6,984,000,000)
Cash flows from financing activities      
Proceeds from issuances of debt 6,854,000,000 12,865,000,000 7,073,000,000
Repayments of debt (3,632,000,000) (7,671,000,000) 0
Debt issuance and deferred financing costs (89,000,000) (172,000,000) (513,000,000)
Debt extinguishment costs 0 (14,000,000) 0
Distributions and dividends to non-controlling interest (185,000,000) (80,000,000) (80,000,000)
Proceeds from exercise of stock options 0 0 2,000,000
Payments related to tax withholdings for share-based compensation (12,000,000) (20,000,000) (61,000,000)
Other 0 0 2,000,000
Net cash provided by (used in) financing activities 2,936,000,000 4,908,000,000 6,423,000,000
Net increase (decrease) in cash, cash equivalents and restricted cash 786,000,000 91,000,000 (1,044,000,000)
Cash, cash equivalents and restricted cash—beginning of period 1,827,000,000 1,736,000,000 2,780,000,000
Cash, cash equivalents and restricted cash—end of period $ 2,613,000,000 $ 1,827,000,000 $ 1,736,000,000